Qilian International Holding Group Ltd
NASDAQ:QLI
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Qilian International Holding Group Ltd
Additional Paid In Capital
Qilian International Holding Group Ltd
Additional Paid In Capital Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Additional Paid In Capital | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Qilian International Holding Group Ltd
NASDAQ:QLI
|
Additional Paid In Capital
$36.4m
|
CAGR 3-Years
44%
|
CAGR 5-Years
24%
|
CAGR 10-Years
N/A
|
|
|
H
|
Hansoh Pharmaceutical Group Company Ltd
HKEX:3692
|
Additional Paid In Capital
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Jiangsu Hengrui Pharmaceuticals Co Ltd
SSE:600276
|
Additional Paid In Capital
¥12.9B
|
CAGR 3-Years
62%
|
CAGR 5-Years
31%
|
CAGR 10-Years
40%
|
|
|
Yunnan Baiyao Group Co Ltd
SZSE:000538
|
Additional Paid In Capital
¥17.6B
|
CAGR 3-Years
-1%
|
CAGR 5-Years
0%
|
CAGR 10-Years
30%
|
|
|
Zhejiang Nhu Co Ltd
SZSE:002001
|
Additional Paid In Capital
¥3.1B
|
CAGR 3-Years
-5%
|
CAGR 5-Years
-7%
|
CAGR 10-Years
16%
|
|
|
S
|
Sichuan Biokin Pharmaceutical Co Ltd
SSE:688506
|
Additional Paid In Capital
¥885.8m
|
CAGR 3-Years
297%
|
CAGR 5-Years
28%
|
CAGR 10-Years
N/A
|
|
Qilian International Holding Group Ltd
Glance View
Qilian International Holding Group Ltd. is a pharmaceutical and chemical company. The company is headquartered in Jiuquan, Gansu and currently employs 283 full-time employees. The company went IPO on 2021-01-12. The firm operates through three segments: Oxytetracycline & Licorice Products and TCMD segment, Fertilizer segment and Heparin Products and Sausage Casing segment. Its main brand is Qilian Shan. The firm principally operates its businesses within the domestic market.
See Also
What is Qilian International Holding Group Ltd's Additional Paid In Capital?
Additional Paid In Capital
36.4m
USD
Based on the financial report for Sep 30, 2023, Qilian International Holding Group Ltd's Additional Paid In Capital amounts to 36.4m USD.
What is Qilian International Holding Group Ltd's Additional Paid In Capital growth rate?
Additional Paid In Capital CAGR 5Y
24%
Over the last year, the Additional Paid In Capital growth was 0%. The average annual Additional Paid In Capital growth rates for Qilian International Holding Group Ltd have been 44% over the past three years , 24% over the past five years .
